摘要
光动力学疗法(PDT)是一个新颖的治疗技术,包含以下三个主要成分:光、一个光敏剂分子和分子氧化,这些都是必需的以达到治疗的效果。通过PDT治疗许多的癌症和皮肤疾病显示出了极大的研究兴趣。通过一个特定的波长的光线照射,光敏剂经过几个反应导致活化氧的产生。活化氧可与许多不同的大分子反应,导致许多细胞结构和生物化学通路的缺陷。PDT介导的体内肿瘤破坏包括多类细胞机制:线粒体的光损伤、溶酶体、细胞核以及细胞膜,这些可以激活凋亡、坏死、吞噬信号,导致细胞的死亡。PDT能够改变肿瘤的微环境,从而减少氧的供给,这就解释了PDT的抗血管生成作用。最终,炎症和免疫反映在PDT治疗长期的影响中起到关键的作用。本综述着重于由光动力疗法在细胞死亡的信号通路中展露出的生物化学作用,脉管系统破坏以及免疫系统的激活。
关键词: 血管生成,凋亡,细胞死亡,细胞机制,免疫学,PDT机制,光动力疗法,光敏剂
Current Medicinal Chemistry
Title:Cellular Changes, Molecular Pathways and the Immune System Following Photodynamic Treatment
Volume: 21 Issue: 35
Author(s): P. Skupin-Mrugalska, L. Sobotta, M. Kucinska, M. Murias, J. Mielcarek and N. Duzgunes
Affiliation:
关键词: 血管生成,凋亡,细胞死亡,细胞机制,免疫学,PDT机制,光动力疗法,光敏剂
摘要: Photodynamic therapy (PDT) is a novel medical technique involving three key components: light, a photosensitizer molecule and molecular oxygen, which are essential to achieve the therapeutic effect. There has been great interest in the use of PDT in the treatment of many cancers and skin disorders. Upon irradiation with light of a specific wavelength, the photosensitizer undergoes several reactions resulting in the production of reactive oxygen species (ROS). ROS may react with different biomolecules, causing defects in many cellular structures and biochemical pathways. PDT-mediated tumor destruction in vivo involves cellular mechanisms with photodamage of mitochondria, lysosomes, nuclei, and cell membranes that activate apoptotic, necrotic and autophagic signals, leading to cell death. PDT is capable of changing the tumor microenvironment, thereby diminishing the supply of oxygen, which explains the antiangiogenic effect of PDT. Finally, inflammatory and immune responses play a crucial role in the long-lasting consequences of PDT treatment. This review is focused on the biochemical effects exerted by photodynamic treatment on cell death signaling pathways, destruction of the vasculature, and the activation of the immune system.
Export Options
About this article
Cite this article as:
Skupin-Mrugalska P., Sobotta L., Kucinska M., Murias M., Mielcarek J. and Duzgunes N., Cellular Changes, Molecular Pathways and the Immune System Following Photodynamic Treatment, Current Medicinal Chemistry 2014; 21 (35) . https://dx.doi.org/10.2174/0929867321666140826120300
DOI https://dx.doi.org/10.2174/0929867321666140826120300 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Glyco-Nanomaterials: Translating Insights from the “Sugar-Code” to Biomedical Applications
Current Medicinal Chemistry Molecular Targeting of Drug Delivery Systems to Cancer
Current Drug Targets Delivery of siRNA to the Target Cell Cytoplasm: Photochemical Internalization Facilitates Endosomal Escape and Improves Silencing Efficiency, In Vitro and In Vivo
Current Pharmaceutical Design The Vanilloid Agonist Resiniferatoxin for Interventional-Based Pain Control
Current Topics in Medicinal Chemistry Melatonin Attenuates Methamphetamine-Induced Neurotoxicity
Current Pharmaceutical Design New Approaches in Glioblastoma Multiforme: The Potential Role of Immune- check Point Inhibitors
Current Cancer Drug Targets The Role of a Human Hematopoietic Mesenchymal Progenitor in Wound Healing and Fibrotic Diseases and Implications for Therapy
Current Stem Cell Research & Therapy Different Gene Therapy Strategies: A Overview for Prostate Cancer
Current Gene Therapy TRPM8, a Sensor for Mild Cooling in Mammalian Sensory Nerve Endings
Current Pharmaceutical Biotechnology An Overview of Targeted Alpha Therapy with <sup>225</sup>Actinium and <sup>213</sup>Bismuth
Current Radiopharmaceuticals Irreversible Protein Kinase Inhibitors
Current Medicinal Chemistry The Drug Targeting and Delivery Approach Applied to Pt-Antitumour Complexes. A Coordination Point of View
Current Medicinal Chemistry Polymeric Nanocarriers: New Endeavors for the Optimization of the Technological Aspects of Drugs
Recent Patents on Biomedical Engineering (Discontinued) Antidotal Effects of Curcumin Against Agents-Induced Cardiovascular Toxicity
Cardiovascular & Hematological Disorders-Drug Targets Berberine Interfered with Breast Cancer Cells Metabolism, Balancing Energy Homeostasis
Anti-Cancer Agents in Medicinal Chemistry The HOX Gene Network as a Potential Target for Cancer Therapy
Current Cancer Therapy Reviews Comparison of Artemisia annua Bioactivities between Traditional Medicine and Chemical Extracts
Current Bioactive Compounds A Review of Molecular Predictors of Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer
Mini-Reviews in Medicinal Chemistry Regulatable Gene Expression Systems for Gene Therapy
Current Gene Therapy Renaissance of the Biologically Active Vitamin A Derivatives: Established and Novel Directed Therapies for Cancer and Chemoprevention
Current Pharmaceutical Design